Efficient, glucose responsive and islet-specific transgene expression by a modified rat insulin promoter

Area of Science:

• Molecular Biology
• Genetics
• Endocrinology

Background:

• The rat insulin promoter (RIP) is crucial for driving gene expression in pancreatic beta cells.
• Improving the efficiency and specificity of RIP is essential for targeted gene therapy and research in diabetes.

Purpose of the Study:

• To engineer a modified rat insulin promoter (RIP3.1) with enhanced efficiency and islet specificity.
• To evaluate the in vitro and in vivo performance of the modified RIP3.1 promoter.

Main Methods:

• In vitro testing of various RIP lengths using luciferase reporter gene assays in different cell types (INS1, alpha, acinar, ductal, fibroblasts).
• In vivo gene delivery using ultrasound-targeted microbubble destruction (UTMD) of a DsRed reporter gene driven by RIP3.1 in rat pancreas.
• Confocal microscopy for detecting DsRed expression and distribution in pancreatic tissues.

Main Results:

• The modified RIP3.1 promoter demonstrated a fivefold increase in activity in INS-1 cells compared to the full-length RIP and CMV promoters.
• RIP3.1 exhibited glucose-dependent regulation and responsiveness to islet transcription factors in vitro.
• In vivo studies showed RIP3.1-driven DsRed expression predominantly in beta-cells and to a lesser extent in alpha-cells, with no expression in exocrine pancreas.

Conclusions:

• The modified RIP3.1 promoter significantly improves gene expression efficiency and specificity for pancreatic islet cells.
• RIP3.1 is a promising tool for targeted gene expression in the endocrine pancreas, avoiding non-islet tissues.